{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:40:36Z","timestamp":1794314436312,"version":"4.9.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/wno.0b013e3182901969","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T10:46:35Z","timestamp":1368701195000},"page":"172-178","source":"Crossref","is-referenced-by-count":103,"title":["Drug-Related Mitochondrial Optic Neuropathies"],"prefix":"10.1097","volume":"33","author":[{"given":"Michelle Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo A.","family":"Sadun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210126","first-page":"423","article-title":"Mitochondrial optic neuropathies.","volume":"72","author":"Sadun","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R2-19-20210126","first-page":"223","article-title":"Lebers hereditary optic neuropathy differentially affects smaller axons in the optic nerve.","volume":"98","author":"Sadun","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R3-19-20210126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies.","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retinal Eye Res"},{"key":"R4-19-20210126","first-page":"881","article-title":"Acquired mitochondrial impairment as a cause of optic nerve disease.","volume":"96","author":"Sadun","year":"1998","journal-title":"Tr Am Soc"},{"key":"R5-19-20210126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1212\/WNL.45.1.11","article-title":"Adenosine triphosphate deficiency: a genre of optic neuropathy.","volume":"45","author":"Rizzo","year":"1995","journal-title":"Neurology"},{"key":"R6-19-20210126","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-0186(01)00129-2","article-title":"Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies.","volume":"40","author":"Carelli","year":"2002","journal-title":"Neurochem Int"},{"key":"R7-19-20210126","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1167\/iovs.12-10452","article-title":"Mathematically modeling the involvement of axons in Lebers hereditary optic neuropathy.","volume":"53","author":"Pan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-19-20210126","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00417-004-1053-1","article-title":"OCT can measure axonal loss in patients with ethambutol-induced optic neuropathy.","volume":"243","author":"Zoumalan","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-19-20210126","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","article-title":"Retinal nerve fiber layer evaluation by optical coherence tomography in Lebers hereditary optic neuropathy.","volume":"112","author":"Barboni","year":"2005","journal-title":"Ophthalmology"},{"key":"R10-19-20210126","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.71.3.192","article-title":"Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy.","volume":"71","author":"Salmon","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"R11-19-20210126","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2009.12.042","article-title":"OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.","volume":"117","author":"Barboni","year":"2010","journal-title":"Ophthalmology"},{"key":"R12-19-20210126","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1167\/iovs.07-0024","article-title":"Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.","volume":"48","author":"Ito","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-19-20210126","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/IJG.0b013e31804d23aa","article-title":"Stratus OCT in dominant optic atrophy: features differentiating it from glaucoma.","volume":"16","author":"Kim","year":"2007","journal-title":"J Glaucoma"},{"key":"R14-19-20210126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1755-3768.2008.01469.x","article-title":"Axonal loss occurs early in dominant optic atrophy.","volume":"88","author":"Milea","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R15-19-20210126","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0002-9343(80)90113-8","article-title":"Methanol poisoning in human subjects. Role for formic acid accumulation in metabolic acidosis.","volume":"8","author":"McMartin","year":"1980","journal-title":"Am Med"},{"key":"R17-19-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0732-8893(97)00217-4","article-title":"The role of copper on ethambutols antimicrobial action and implications for ethambutol-induced optic neuropathy.","volume":"30","author":"Kozak","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R18-19-20210126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00417-009-1227-y","article-title":"Infliximab and anterior optic neuropathy: case report and review of the literature.","volume":"248","author":"Chan","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-19-20210126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNO.0b013e31818f138f","article-title":"Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year.","volume":"28","author":"Sadun","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"R21-19-20210126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/taap.1999.8846","article-title":"Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc.","volume":"162","author":"Yoon","year":"2000","journal-title":"Toxicol Appl Pharmacol"},{"key":"R22-19-20210126","doi-asserted-by":"crossref","first-page":"608534","DOI":"10.1155\/2012\/608534","article-title":"The neurological complications of nutritional deficiency following bariatric surgery.","volume":"2012","author":"Becker","year":"2012","journal-title":"J Obes"},{"key":"R23-19-20210126","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.survophthal.2010.02.002","article-title":"Combined optic neuropathy and myelopathy secondary to copper deficiency.","volume":"55","author":"Pineles","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"R24-19-20210126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0002-9394(14)78122-X","article-title":"Zinc deficiency and visual impairment.","volume":"85","author":"Leopold","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"R25-19-20210126","first-page":"191","article-title":"Prevention of ocular toxicity of ethambutol: study of zincaemia and chromatic analysis.","volume":"1","author":"Delacoux","year":"1978","journal-title":"J Fr Ophtalmol"},{"key":"R26-19-20210126","first-page":"80","article-title":"The incidence of optic neuropathy in 84 patients treated with ethambutol.","volume":"2","author":"De Palma","year":"1989","journal-title":"Metab Pediatr Syst Ophthalmol"},{"key":"R27-19-20210126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2008.11.006","article-title":"Ethambutol-induced toxicity is mediated by zinc and lysosomal membrane permeabilization in cultured retinal cells.","volume":"235","author":"Chung","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"R28-19-20210126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archopht.1962.00960020566009","article-title":"Ocular manifestations of ethambutol, toxic amblyopia after administration of an experimental antituberculous drug.","volume":"67","author":"Carr","year":"1962","journal-title":"Arch Ophthalmol"},{"issue":"suppl","key":"R29-19-20210126","first-page":"32","article-title":"Ethambutol. A review with special reference to ocular toxicity.","volume":"50","author":"Citron","year":"1969","journal-title":"Tubercle"},{"key":"R30-19-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004397-197101120-00009","article-title":"Drugs having a toxic effect on the optic nerve.","volume":"11","author":"Leibold","year":"1971","journal-title":"Int Ophthalmol Clin"},{"key":"R31-19-20210126","first-page":"355","article-title":"Toxic optic neuropathy and its experimental production.","volume":"96","author":"Bronte Stewart","year":"1976","journal-title":"Trans Ophthalmol Soc UK"},{"key":"R32-19-20210126","first-page":"61","article-title":"Adverse drug interactions in TB therapy: risks and recommendations.","volume":"37","author":"Yoshikawa","year":"1982","journal-title":"Geriatrics"},{"key":"R33-19-20210126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1755-3768.1987.tb07008.x","article-title":"Ocular ethambutol toxicity.","volume":"65","author":"Fledelius","year":"1987","journal-title":"Acta Ophthalmol"},{"key":"R34-19-20210126","first-page":"212","article-title":"Toxic ocular effects of ethambutol.","volume":"137","author":"Kahana","year":"1987","journal-title":"Can Med Assoc J"},{"key":"R35-19-20210126","first-page":"84","article-title":"Should ethambutol be barred J Clin Neuroophthalmol.","volume":"7","author":"Smith","year":"1987","journal-title":""},{"key":"R36-19-20210126","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(88)90662-9","article-title":"Ethambutol and the eye.","volume":"2","author":"Kahana","year":"1988","journal-title":"Lancet"},{"key":"R37-19-20210126","first-page":"37","article-title":"Ethambutol toxic neuroretinopathy in Bangladesh.","volume":"5","author":"Rahman","year":"1989","journal-title":"Pakistan J Ophthalmol"},{"key":"R38-19-20210126","first-page":"15","article-title":"Ocular ethambutol toxicity: is it reversible J Clin Neuroophthalmol.","volume":"13","author":"Kumar","year":"1993","journal-title":""},{"key":"R39-19-20210126","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3341\/kjo.1997.11.2.106","article-title":"Optic neuropathy associated with ethambutol in Koreans.","volume":"11","author":"Choi","year":"1997","journal-title":"Korean J Ophthalmol"},{"key":"R40-19-20210126","first-page":"33","article-title":"U.S. Public Health Service experience with ethambutol. International Congress of Chemotherapy, Vienna.","volume":"6","author":"Murray","year":"1967","journal-title":""},{"key":"R41-19-20210126","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/106002809302700126","article-title":"Ethambutol-induced ocular toxicity revisited.","volume":"27","author":"Alvarez","year":"1993","journal-title":"Ann Pharmacother"},{"key":"R42-19-20210126","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00007611-199409000-00001","article-title":"Neurotoxicity of antibacterial therapy.","volume":"87","author":"Thomas","year":"1994","journal-title":"South Med J"},{"key":"R43-19-20210126","first-page":"622","article-title":"Ethambutol and optic neuropathy.","volume":"86","author":"Chuenkongkaew","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"R44-19-20210126","first-page":"56","article-title":"Ocular toxicity of ethambutol.","volume":"12","author":"Chan","year":"2006","journal-title":"Hong Kong Med J"},{"key":"R45-19-20210126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","article-title":"Ocular adverse effects associated with systemic medications: recognition and management.","volume":"67","author":"Santaella","year":"2007","journal-title":"Drugs"},{"key":"R46-19-20210126","first-page":"1209","article-title":"Two cases of bitemporal hemianopsia due to ethambutol.","volume":"23","author":"Asayama","year":"1969","journal-title":"Jpn J Clin Ophthalmol"},{"key":"R47-19-20210126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/WNO.0b013e318205a148","article-title":"Bitemporal visual field defects in ethambutol-induced optic neuropathy.","volume":"31","author":"Kho","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R48-19-20210126","doi-asserted-by":"crossref","first-page":"274","DOI":"10.47102\/annals-acadmedsg.V35N4p274","article-title":"Ethambutol-associated optic neuropathy.","volume":"35","author":"Lim","year":"2006","journal-title":"Ann Acad Med Singapore"},{"key":"R49-19-20210126","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjophthalmol-2012-301870","article-title":"Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan.","volume":"96","author":"Chen","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R51-19-20210126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.200407-863OC","article-title":"Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease.","volume":"172","author":"Griffith","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R52-19-20210126","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9394(74)90684-9","article-title":"Ocular toxicity from ethambutol.","volume":"77","author":"Barron","year":"1974","journal-title":"Am J Ophthalmol"},{"key":"R53-19-20210126","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/thx.41.10.737","article-title":"Ocular toxicity from ethambutol.","volume":"41","author":"Citron","year":"1986","journal-title":"Thorax"},{"key":"R56-19-20210126","first-page":"1318","article-title":"Ethambutol dosage for the treatment of children: literature review and recommendations.","volume":"10","author":"Donald","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R57-19-20210126","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/112067210901900323","article-title":"Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography.","volume":"19","author":"Kim","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R58-19-20210126","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10792-009-9293-z","article-title":"Risk factors for ethambutol optic toxicity.","volume":"30","author":"Talbert Estlin","year":"2010","journal-title":"Int Ophthalmol"},{"key":"R59-19-20210126","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/jop.1997.13.473","article-title":"Reversibility of ethambutol optic neuropathy.","volume":"13","author":"Tsai","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"key":"R60-19-20210126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/jop.1995.11.411","article-title":"Visual function in recovered ethambutol optic neuropathy.","volume":"11","author":"Woung","year":"1995","journal-title":"J Ocul Pharmaco Ther"},{"key":"R61-19-20210126","first-page":"77","article-title":"Optic neuropathy in ethambutol treated renal tuberculosis.","volume":"7","author":"De Vita","year":"1987","journal-title":"J Clin Neuroophthalmol"},{"key":"R62-19-20210126","first-page":"124","article-title":"Best catch from NANOSNET. II. Monitoring for ethambutol optic nerve toxicity.","volume":"22","author":"Cornblath","year":"2002","journal-title":"J Neuroophthal"},{"key":"R63-19-20210126","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/14740338.5.5.615","article-title":"Update on ethambutol optic neuropathy.","volume":"5","author":"Fraunfelder","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"R64-19-20210126","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jop.2011.0095","article-title":"Visual function in patients on ethambutol therapy for tuberculosis.","volume":"28","author":"Kandel","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"R65-19-20210126","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bjo.2008.148502","article-title":"Prospective evaluation of visual function for early detection of ethambutol toxicity.","volume":"93","author":"Menon","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R66-19-20210126","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bjo.2006.113118","article-title":"Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.","volume":"91","author":"Chai","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R67-19-20210126","first-page":"1011","article-title":"Optic neuritis and optic atrophy following chloramphenicol in cystic fibrosis patients.","volume":"74","author":"Harley","year":"1970","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R69-19-20210126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1242\/jcs.7.2.501","article-title":"Chloramphenicol-related changes in mitochondrial ultrastructure.","volume":"7","author":"Smith","year":"1970","journal-title":"J Cell Sci"},{"key":"R70-19-20210126","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.1980.01020040269011","article-title":"Chloramphenicol optic neuropathy.","volume":"98","author":"Godel","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"R71-19-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/345744","article-title":"Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.","volume":"36","author":"Birmingham","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R72-19-20210126","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ophtha.2003.09.042","article-title":"Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.","volume":"111","author":"Fiscella","year":"2004","journal-title":"Ophthalmology"},{"key":"R73-19-20210126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/01.wnl.0000201313.24970.b8","article-title":"Linezolid-associated toxic optic neuropathy.","volume":"66","author":"Rucker","year":"2006","journal-title":"Neurology"},{"key":"R74-19-20210126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00041327-200503000-00005","article-title":"Optic neuropathy associated with linezolid treatment.","volume":"25","author":"McKinley","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"R75-19-20210126","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajo.2004.11.047","article-title":"Linezolid-induced optic neuropathy.","volume":"139","author":"Saijo","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R76-19-20210126","first-page":"111","article-title":"Linezolid-induced optic neuropathy: a mitochondrial disorder Br J Ophthalmol.","volume":"91","author":"Javaheri","year":"2007","journal-title":""},{"key":"R77-19-20210126","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis.","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R78-19-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathiesdisease mechanisms and therapeutic strategies.","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"R79-19-20210126","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjo.45.8.555","article-title":"Blindness during streptomycin and chloramphenicol therapy.","volume":"45","author":"Walker","year":"1961","journal-title":"Br J Ophthalmol"},{"key":"R80-19-20210126","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs.","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat Med"},{"key":"R81-19-20210126","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/15216540600791571","article-title":"Mitochondrial AZT metabolism.","volume":"58","author":"Samuels","year":"2006","journal-title":"IUBMB Life"},{"key":"R82-19-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000134943","article-title":"Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.","volume":"82","author":"Scruggs","year":"2008","journal-title":"Pharmacology"},{"key":"R83-19-20210126","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9394(00)00716-9","article-title":"Leber hereditary optic neuropathy associated with antiretroviral therapy for human immunodeficiency virus infection.","volume":"131","author":"Shaikh","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R84-19-20210126","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.eye.6700362","article-title":"Lebers hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus.","volume":"17","author":"Mackey","year":"2003","journal-title":"Eye (Lond)"},{"key":"R85-19-20210126","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s10384-005-0308-7","article-title":"Lebers hereditary optic neuropathy precipitated by ethambutol.","volume":"50","author":"Ikeda","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"R86-19-20210126","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1442-9071.2010.02240.x","article-title":"Antituberculosis medication as a possible epigenetic factor of Lebers hereditary optic neuropathy.","volume":"38","author":"Seo","year":"2010","journal-title":"Clin Experiment Ophthalmol"},{"key":"R87-19-20210126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mito.2004.05.002","article-title":"Erythromycin as a potential precipitating agent in the onset of Lebers hereditary optic neuropathy.","volume":"4","author":"Luca","year":"2004","journal-title":"Mitochondrion"},{"key":"R88-19-20210126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mito.2009.11.004","article-title":"Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity.","volume":"10","author":"Guillet","year":"2010","journal-title":"Mitochondrion"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e3182901969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T19:56:26Z","timestamp":1688241386000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201306000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e3182901969","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}